Skip to Content

Theophylline Extended-Release Tablets

Last Updated: January 26, 2018
Status: Current

Theophylline Extended-Release Tablets

Products Affected - Description
  • Theophylline extended release tablet, Teva
    100 mg, bottle, 100 count (NDC 50111-0483-01)
    100 mg, bottle, 500 count (NDC 50111-0483-02)

200 mg, bottle, 100 count (NDC 50111-0482-01)
200 mg, bottle, 500 count (NDC 50111-0482-02)
200 mg, bottle, 1000 count (NDC 50111-0482-03)
300 mg, bottle, 100 count (NDC 50111-0459-01)
300 mg, bottle, 500 count (NDC 50111-0459-02)
300 mg, bottle, 1000 count (NDC 50111-0459-03)
Reason for the Shortage
    • Major has discontinued theophylline extended-release tablets.
    • Teva cannot provide a reason for the shortage.
Available Products
  • There are no presentations available.

Estimated Resupply Dates

  • Teva has theophylline extended-release tablets temporarily unavailable and the company cannot estimate a release date.

Updated

January 26, 2018; October 5, June 25 and 14, January 13, 2017; October 19, August 15, July 20, June 9, May 13, April 14, February 5, 2016; December 16, 2015, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide